Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 55 results.
User Information
Export Records
  1. 1.   Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter
  2. Robey, Robert W.; Robinson, Andrea N.; Ali-Rahmani, Fatima; Huff, Lyn M.; Lusvarghi, Sabrina; Vahedi, Shahrooz; Hotz, Jordan M.; Warner,Andrew; Butcher,Donna; Matta,Jennifer; Edmondson,Elijah; Lee, Tobie D.; Roth, Jacob S.; Lee, Olivia W.; Shen, Min; Tanner, Kandice; Hall, Matthew D.; Ambudkar, Suresh; Gottesman, Michael M.
  3. SCIENTIFIC REPORTS. 2021, Dec 17; 11(1):
  1. 2.   Sterically induced conformational restriction: Discovery and preclinical evaluation of novel pyrrolo[3,2-d]pyrimidines as microtubule targeting agents
  2. Pavana, Roheeth Kumar; Shah, Khushbu; Gentile, Taylor; Dybdal-Hargreaves, Nicholas F.; Risinger, April L.; Mooberry, Susan L.; Hamel, Ernest; Gangjee, Aleem
  3. BIOORGANIC & MEDICINAL CHEMISTRY. 2018, NOV 1; 26(20): 5470-5478.
  1. 3.   Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
  2. Seaman, Steven; Zhu, Zhongyu; Saha, Saurabh; Zhang, Xiaoyan M; Yang, Mi Young; Hilton, Mary; Morris, Karen; Szot, Christopher; Morris, Holly; Swing, Debbie; Tessarollo, Lino; Smith, Sean W; Degrado, Sylvia; Borkin, Dmitry; Jain, Nareshkumar; Scheiermann, Julia; Feng, Yang; Wang, Yanping; Li, Jinyu; Welsch, Dean; DeCrescenzo, Gary; Chaudhary, Ritu; Zudaire, Enrique; Klarmann, Kimberly; Keller, Jonathan; Dimitrov, Dimiter; St Croix, Brad
  3. Cancer Cell. 2017, Apr 10; 31(4): 501-515.e8.
  1. 4.   Human Dosimetry and Preliminary Tumor Distribution of (18)F-Fluoropaclitaxel in Healthy Volunteers and Newly Diagnosed Breast Cancer Patients Using PET/CT
  2. Kurdziel, K. A.; Kalen, J. D.; Hirsch, J. I.; Wilson, J. D.; Bear, H. D.; Logan, J.; McCumisky, J.; Moorman-Sykes, K.; Adler, S.; Choyke, P. L.
  3. Journal of Nuclear Medicine. 2011, Sep; 52(9): 1339-1345.
  1. 5.   Multidrug Efflux Pumps and Cancer Stem Cells: Insights Into Multidrug Resistance and Therapeutic Development
  2. Moitra, K.; Lou, H.; Dean, M.
  3. Clinical Pharmacology & Therapeutics. 2011, Apr; 89(4): 491-502.
  1. 6.   CCAAT/Enhancer-Binding Proteins (C/EBP)-alpha and -beta Are Essential for Ovulation, Luteinization, and the Expression of Key Target Genes
  2. Fan, H. Y.; Liu, Z. L.; Johnson, P. F.; Richards, J. S.
  3. Molecular Endocrinology. 2011, Feb; 25(2): 253-268.
  1. 7.   Impact of ABCB1 Allelic Variants on QTc Interval Prolongation
  2. Sissung, T. M.; Gardner, E. R.; Piekarz, R. L.; Howden, R.; Chen, X. H.; Woo, S.; Franke, R.; Clark, J. A.; Miller-DeGraff, L.; Steinberg, S. M.; Venzon, D.; Liewehr, D.; Kleeberger, S. R.; Bates, S. E.; Price, D. K.; Rosing, D. R.; Cabell, C.; Sparreboom, A.; Figg, W. D.
  3. Clinical Cancer Research. 2011, Feb; 17(4): 937-946.
  1. 8.   Evolution of ABC transporters by gene duplication and their role in human disease
  2. Moitra, K.; Dean, M.
  3. Biological Chemistry. 2011, Jan; 392(1-2): 29-37.
  1. 9.   Synthesis and Discovery of Water-Soluble Microtubule Targeting Agents that Bind to the Colchicine Site on Tubulin and Circumvent Pgp Mediated Resistance
  2. Gangjee, A.; Zhao, Y.; Lin, L.; Raghavan, S.; Roberts, E. G.; Risinger, A. L.; Hamel, E.; Mooberry, S. L.
  3. Journal of Medicinal Chemistry. 2010, Nov; 53(22): 8116-8128.
  1. 10.   Short-Course Raltegravir Intensification Does Not Reduce Persistent Low-Level Viremia in Patients with HIV-1 Suppression during Receipt of Combination Antiretroviral Therapy
  2. McMahon, D.; Jones, J.; Wiegand, A.; Gange, S. J.; Kearney, M.; Palmer, S.; McNulty, S.; Metcalf, J. A.; Acosta, E.; Rehm, C.; Coffin, J. M.; Mellors, J. W.; Maldarelli, F.
  3. Clinical Infectious Diseases. 2010, Mar; 50(6): 912-919.
  1. 11.   Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
  2. Sissung, T. M.; Baum, C. E.; Kirkl, C. T.; Gao, R.; Gardner, E. R.; Figg, W. D.
  3. Molecular Biotechnology. 2010, Feb; 44(2): 152-167.
  1. 12.   Identification of a Potential Pharmacological Sanctuary for HIV Type 1 in a Fraction of CD4(+) Primary Cells
  2. Valentin, A.; Morrow, M.; Poirier, R. H.; Aleman, K.; Little, R.; Yarchoan, R.; Pavlakis, G. N.
  3. Aids Research and Human Retroviruses. 2010, Jan; 26(1): 79-88.
  1. 13.   Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma
  2. Bates, S. E.; Zhan, Z. R.; Steadman, K.; Obrzut, T.; Luchenko, V.; Frye, R.; Robey, R. W.; Turner, M.; Gardner, E. R.; Figg, W. D.; Steinberg, S. M.; Ling, A.; Fojo, T.; To, K. W.; Piekarz, R. L.
  3. British Journal of Haematology. 2010, Jan; 148(2): 256-267.
  1. 14.   Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
  2. Gardner, E. R.; Smith, N. F.; Figg, W. D.; Sparreboom, A.
  3. Journal of experimental & clinical cancer research : CR. 2009 28: 99.
  1. 15.   Botryllamides: Natural Product Inhibitors of ABCG2
  2. Henrich, C. J.; Robey, R. W.; Takada, K.; Bokesch, H. R.; Bates, S. E.; Shukla, S.; Ambudkar, S. V.; McMahon, J. B.; Gustafson, K. R.
  3. Acs Chemical Biology. 2009 4(8): 637-647.
  1. 16.   The ABC transporter gene family of Daphnia pulex
  2. Sturm, A.; Cunningham, P.; Dean, M.
  3. Bmc Genomics. 2009 10 AR(170): 1-18.
  1. 17.   Lack of ABC transporter autoinduction in mice following long-term exposure to imatinib
  2. Gardner, E. R.; Sparreboom, A.; Verweij, J.; Figg, W. D.
  3. Cancer Biology & Therapy. 2008 7(3): 412-415.
  1. 18.   Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
  2. Potocnik, U.; Glavac, D.; Dean, M.
  3. Cancer Genetics and Cytogenetics. 2008 183(1): 28-34.
  1. 19.   Expression of 25 human ABC transporters in the yeast Pichia pastoris and characterization of the purified ABCC3 ATPase activity
  2. Chloupkova, M.; Pickert, A.; Lee, J. Y.; Souza, S.; Trinh, Y. T.; Connelly, S. M.; Dumont, M. E.; Dean, M.; Urbatsch, I. L.
  3. Biochemistry. 2007, Jul; 46(27): 7992-8003.
  1. 20.   Purification and ATP hydrolysis of the putative cholesterol transporters ABCG5 and ABCG8
  2. Wang, Z. L.; Stalcup, L. D.; Harvey, B. J.; Weber, J.; Chloupkova, M.; Dumont, M. E.; Dean, M.; Urbatsch, I. L.
  3. Biochemistry. 2006, Aug; 45(32): 9929-9939.
  1. 21.   Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib
  2. Gardner, E. R.; Burger, H.; van Schaik, R. H.; van Oosterom, A. T.; de Bruijn, E. A.; Guetens, G.; Prenen, H.; de Jong, F. A.; Baker, S. D.; Bates, S. E.; Figg, W. D.; Verweij, J.; Sparreboom, A.; Nooter, K.
  3. Clinical Pharmacology & Therapeutics. 2006, Aug; 80(2): 192-201.
  1. 22.   Lack of sex-related differences in saquinavir pharmacokinetics in an HIV-seronegative cohort
  2. Robertson, S. M.; Formentini, E.; Alfaro, R. M.; Natarajan, V.; Falloon, J.; Penzak, S. R.
  3. British Journal of Clinical Pharmacology. 2006, Apr; 61(4): 379-388.
  1. 23.   A high-throughput cell-based assay for inhibitors of ABCG2 activity
  2. Henrich, C. J.; Bokesch, H. R.; Dean, M.; Bates, S. E.; Robey, R. W.; Goncharova, E. I.; Wilson, J. A.; McMahon, J. B.
  3. Journal of Biomolecular Screening. 2006, Mar; 11(2): 176-183.
  1. 24.   CB694, a novel antimitotic with antitumor activities
  2. Weiderhold, K. N.; Randall-Hiubek, D. A.; Polin, L. A.; Hamel, E.; Mooberry, S. L
  3. International Journal of Cancer. 2006, FEB 15; 118(4): 1032-1040.
  1. 25.   Prednisolone pharmacokinetics in the presence and absence of Ritonavir after oral prednisone administration to healthy volunteers
  2. Penzak, S. R.; Fomnentini, E.; Alfaro, R. M.; Long, M.; Natarajan, V.; Kovacs, J.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2005, DEC 15; 40(5): 573-580.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel